ATP5F1A and gastric cancer: Therefore, inhibition of ATP5A1 is suggested to be further studied as a therapeutic tool for survival improvement in GC patients that show overexpression of this gene.Although our study suggested the probable relevance between our identified genes/CREs and GC pathogenesis, little is known about the relevance of these genes/CREs to GC.